Detailed price information for Windtree Therapeutics Inc (WINT-Q) from The Globe and Mail including charting and trades.

Detailed price information for Windtree Therapeutics Inc (WINT-Q) from The Globe and Mail including charting and trades.

About Windtree Therapeutics, Inc. Windtree Therapeutics, Inc. is a diversified company with several divisions, including a cryptocurrency treasury strategy and two promising therapeutic pipelines for ...

Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced it has signed a $500 million equity line of credit (ELOC ...

Windtree Therapeutics has entered agreements to raise up to $520 million for BNB cryptocurrency acquisition, with a total commitment nearing $700 million. The company plans to direct 99% of funds ...

Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.

WARRINGTON, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT) is excited to announce it has entered into a $60 million securities ...

Windtree Therapeutics, a Nasdaq listed biotechnology company, has plans to raise up to $200 million to build a treasury of BNB, the native cryptocurrency of BNB Chain. Warrington, Pennsylvia-based ...

Windtree Therapeutics, Inc. (WINT) announced it has entered into a $60 million securities purchase agreement led by Build and Build Corp, with potential for up to $140 million in additional future ...

Windtree Therapeutics Announces Up To $520 Million in New Funding to Amplify BNB Cryptocurrency Treasury Strategy Jul. 24, 2025 9:00 AM ET Windtree Therapeutics, Inc. (WINT) ...

Windtree Therapeutics, Inc. has announced a strategic partnership with Kraken, a prominent global cryptocurrency platform, to enhance its BNB Crypto Treasury Strategy. This partnership includes ...

Istaroxime was added to currently available inotropes and vasopressors in the study - no new safety signals were identified and physiological improvements were consistent with istaroxime responses in ...